Work

Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz095

Authors: N. Vasan, P. Razavi, J.L. Johnson, H. Shao, E. Reznik, M.L. Smith, R. Sebra, L.C. Cantley, M. Scaltriti, J. Baselga

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Icahn School of Medicine at Mount Sinai, AstraZeneca (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2946677666

FWCI: 0.415

Cites:

Cited by: 7

Related to: 10